Insider trade

Eastman Chemical Company (EMN): Director received 480 units

Kim Ann Mink, Director at Eastman Chemical Company, reported a grant / award of 480 units.

480
Derivative units
Traded
Oct 7, 2026
Filed
Oct 9, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

    What came next

    1. Oct 16, 2026Company filing · Form 8-K · Bylaws or charter, Other newsChanged its bylaws, charter or fiscal year, and reported other company news
    2. Oct 29, 2026Company filing · Form 8-K · ResultsReported its results
    3. Nov 6, 2026Insider · First insider buy since Aug 2025Officer purchased ~$160K of EMN shares in the open market
    4. Nov 12, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
    View the official recordSEC Form 4

    How to read SEC Form 4

    Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

    Full guide: What is an SEC Form 4?

    What else is on file for Eastman Chemical Company

    For Eastman Chemical Company, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

    These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EMN page.

    Other recent filings by Kim Ann Mink, Director

    The full history of Kim Ann Mink, Director is on the profile page.

    How this filing works

    Explore the data

    Other disclosures at Eastman Chemical Company

    Everything OQRO holds on this company is on its EMN page.

    This is one filing. OQRO holds the rest

    Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

    OQRO is free for everyone. No card, no trial

    OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data